Seldon Capital’s Labcorp LH Stock Holding History

Seldon Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-97	Closed	-$19.5K	–	159
2022 Q4	$19.5K	Hold	97	–	–	0.02%	202
2022 Q3	$17K	Hold	97	–	–	0.01%	217
2022 Q2	$19K	Hold	97	–	–	0.01%	225
2022 Q1	$22K	Hold	97	–	–	0.01%	224
2021 Q4	$26K	Buy	+97	New	+$24K	0.02%	219

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Seldon Capital's LH Position: Q1 2023 in Review

Seldon Capital sold out of Labcorp (LH) in Q1 2023, closing a stake of 97 shares — an estimated $19.5K sold.

Seldon Capital first reported a position in LH in Q4 2021 and held it in 5 quarters. The position peaked at $26K in Q4 2021. 940 funds tracked by Wall St. Rank hold LH as of Q1 2023.

Seldon Capital reported no remaining Labcorp position as of Q1 2023 after selling out during the quarter.
Seldon Capital sold 97 Labcorp shares in Q1 2023, an estimated $19.5K.
Seldon Capital first reported a position in Labcorp in Q4 2021 and held it in 5 quarters.
Seldon Capital's Labcorp position peaked at $26K in Q4 2021.
940 funds tracked by Wall St. Rank held Labcorp as of Q1 2023.

Based on Seldon Capital's 13F filing for Q1 2023, filed 12 May 2023.